CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. - LEAD CASE

1:15-cv-13099

Overview

Case Number 1:15-cv-13099
Filing Date 2015-08-06
Status Litigation filed
Court District Court, D. Massachusetts (mad)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:145 Patent Infringement
Jury Demand Both

Parties

Defendant

Collegium Pharmaceutical, Inc. - LEAD CASE Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Purdue Pharma, L.P. NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Massachusetts (mad)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 21 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (21): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10407434
Process for preparing oxycodone compositions
Filed: 2019-01-30
Issued: 2019-09-10
Active (12.2 yrs remaining)
Expires: 2039-01-30
US9693961
Pharmaceutical formulation containing gelling agent
Filed: 2016-02-04
Issued: 2017-07-04
Active (9.2 yrs remaining)
Expires: 2036-02-04
US9522919
Oxycodone compositions
Filed: 2015-05-29
Issued: 2016-12-20
Active (8.5 yrs remaining)
Expires: 2035-05-29
US9073933
Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Filed: 2012-02-06
Issued: 2015-07-07
Expired (Term Ended)
Expires: 2026-02-11

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

21

Dispositive

8

Granted

0

Denied

0

Pending / Review

21

Motions by Category

Motion to Dismiss 8 Procedural / Extension Motion 11 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
REPLY to Response to 276 MOTION to Dismiss Plaintiff's First Amended Complaint filed by Collegium Pharmaceutical, Inc.. (Holdreith, Jacob) (Entered: 06/28/2021)
Entry #287 • 2021-06-28 Document →
Motion to Dismiss Pending / Under Review
MOTION for Leave to File Reply in Support of Its Motion to Dismiss Plaintiffs' First Amended Complaint by Collegium Pharmaceutical, Inc..(Holdreith, Jacob) (Ent...
Entry #285 • 2021-06-23 Document →
Motion to Dismiss Pending / Under Review
MEMORANDUM in Opposition re 276 MOTION to Dismiss Plaintiff's First Amended Complaint filed by Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technolo...
Entry #284 • 2021-06-18 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss Plaintiff's First Amended Complaint by Collegium Pharmaceutical, Inc..(Sullivan, Christopher) (Entered: 06/04/2021)
Entry #276 • 2021-06-04 Document →
Motion to Dismiss Pending / Under Review
MEMORANDUM in Support re 276 MOTION to Dismiss Plaintiff's First Amended Complaint filed by Collegium Pharmaceutical, Inc.. (Sullivan, Christopher) (Entered: 06...
Entry #277 • 2021-06-04 Document →
Motion to Dismiss Pending / Under Review
NOTICE by Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies re 265 MOTION to Dismiss Complaint Alleging Infringement of U.S. Patent No. 10,4...
Entry #273 • 2021-05-21 Document →

Docket Entries

(24 total)
Motion to Dismiss Pending / Under Review

MOTION to Dismiss Complaint Alleging Infringement of U.S. Patent No. 10,407,434 by Collegium Pharmaceutical, Inc..(Sullivan, Christopher) (Entered: 05/07/2021)

Entry #265 • 2021-05-07
1
Motion to Dismiss Pending / Under Review

MEMORANDUM in Support re 265 MOTION to Dismiss Complaint Alleging Infringement of U.S. Patent No. 10,407,434 filed by Collegium Pharmaceutical, Inc.. (Sullivan, Christopher) (Entered: 05/07/2021)

Entry #266 • 2021-05-07
1
Procedural / Extension Motion Pending / Under Review

Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Kevin V. McCarthy and Adam M. Nicolais Filing fee: $ 200, receipt number 0101-8764865 by Purdue Pharma, L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies. (Attachments: # 1 Affidavit Declaration of K. McCarthy, # 2 Affidavit Declaration of A. Nicolais)(Morrison, Christopher) (Entered: 05/07/2021)

Entry #267 • 2021-05-07
1
Procedural / Extension Motion Pending / Under Review

Chief Judge F. Dennis Saylor, IV: ELECTRONIC ORDER entered ALLOWING 267 Motion for Leave to Appear Pro Hac Vice Added Kevin V. McCarthy and Adam M. Nicolais. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Vieira, Leonardo) (Entered: 05/10/2021)

Entry #268 • 2021-05-10
1
Procedural / Extension Motion Pending / Under Review

MOTION for Leave to Appear Pro Hac Vice for admission of Emily Tremblay, Ellen Levish Filing fee: $ 200, receipt number 0101-8769752 by Collegium Pharmaceutical, Inc.. (Attachments: # 1 Affidavit Certficate of Ellen Levish, # 2 Affidavit Certificate of Emily Tremblay)(Sullivan, Christopher) (Entered: 05/11/2021)

Entry #269 • 2021-05-11
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc